• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures.

作者信息

Smolen J S, Sokka T, Pincus T, Breedveld F C

机构信息

University of Vienna and Krankenhaus Lainz, Division of Rheumatology, Internal Medicine III, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

出版信息

Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S209-10.

PMID:14969080
Abstract
摘要

相似文献

1
A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures.一种针对类风湿关节炎的治疗算法建议：强化治疗、甲氨蝶呤及定量措施。
Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S209-10.
2
Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model.衡量类风湿性关节炎治疗的疗效和有效性：是时候改变我们的思维并采用新模型了。
J Rheumatol. 2004 Dec;31(12):2317-9.
3
An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures.在两项阿巴西普临床试验中，仅采用患者报告的结局指标的一个指数——患者指数数据3常规评估（RAPID3）：结果与疾病活动评分（DAS28）以及其他包含医生报告指标的RAPID指数相似。
Rheumatology (Oxford). 2008 Mar;47(3):345-9. doi: 10.1093/rheumatology/kem364. Epub 2008 Jan 31.
4
Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate.类风湿关节炎患者在接受甲氨蝶呤治疗时使用左氧氟沙星。
South Med J. 2007 Feb;100(2):135-9. doi: 10.1097/01.smj.0000254190.54327.3b.
5
The Utrecht experience with different treatment strategies in early rheumatoid arthritis.乌得勒支在早期类风湿性关节炎不同治疗策略方面的经验。
Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S165-8.
6
Long-term followup of patients receiving combined therapy with cyclosporine and methotrexate.
Arthritis Rheum. 1998 Sep;41(9):1703-4. doi: 10.1002/1529-0131(199809)41:9<1703::AID-ART25>3.0.CO;2-D.
7
Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.羟氯喹、硫代苹果酸金钠与甲氨蝶呤联合治疗早期类风湿性关节炎的安全性
Rev Rhum Engl Ed. 1997 Jul-Sep;64(7-9):521-2.
8
DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established disease.
Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S169-73.
9
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.在 16 周的治疗后，甲氨蝶呤联合其他 DMARD 与甲氨蝶呤单药治疗在中高剂量糖皮质激素桥接早期类风湿关节炎缓解诱导方面并无优势：CareRA 试验。
Ann Rheum Dis. 2015 Jan;74(1):27-34. doi: 10.1136/annrheumdis-2014-205489. Epub 2014 Oct 30.
10
Adding baseline protein biomarkers to clinical predictors does not enhance prediction of treatment response to a methotrexate strategy in early rheumatoid arthritis.在临床预测指标中加入基线蛋白质生物标志物并不能增强对早期类风湿关节炎甲氨蝶呤治疗策略反应的预测。
Ann Rheum Dis. 2019 Jan;78(1):142-144. doi: 10.1136/annrheumdis-2018-213767. Epub 2018 Aug 29.

引用本文的文献

1
The prevalence and types of discordance between physician perception and objective data from standardized measures of rheumatoid arthritis disease activity in real-world clinical practice in the US.美国实际临床实践中，医生认知与类风湿关节炎疾病活动标准化测量的客观数据之间不一致的患病率及类型。
BMC Rheumatol. 2019 Jul 4;3:25. doi: 10.1186/s41927-019-0073-8. eCollection 2019.
2
Real benefits of ultrasound evaluation of hand and foot synovitis for better characterisation of the disease activity in rheumatoid arthritis.超声评估手足滑膜炎对类风湿关节炎疾病活动更好的特征化的实际获益。
Eur Radiol. 2019 Nov;29(11):6345-6354. doi: 10.1007/s00330-019-06187-8. Epub 2019 Apr 26.
3
The clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of life.
聚乙二醇化赛妥珠单抗（CZP）治疗类风湿关节炎的临床疗效与安全性：聚焦长期使用、患者考量及对生活质量的影响
Open Access Rheumatol. 2009 Jul 13;1:95-106. doi: 10.2147/oarrr.s4904. eCollection 2009.
4
Clinical outcome measures in juvenile idiopathic arthritis.青少年特发性关节炎的临床结局指标
Pediatr Rheumatol Online J. 2016 Apr 18;14(1):23. doi: 10.1186/s12969-016-0085-5.
5
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.EULAR 推荐的使用合成和生物疾病修饰抗风湿药物治疗类风湿关节炎的建议。
Ann Rheum Dis. 2010 Jun;69(6):964-75. doi: 10.1136/ard.2009.126532. Epub 2010 May 5.
6
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search.治疗类风湿关节炎的靶向治疗证据：系统文献检索结果。
Ann Rheum Dis. 2010 Apr;69(4):638-643. doi: 10.1136/ard.2009.123976.
7
Elderly onset rheumatoid arthritis: differential diagnosis and choice of first-line and subsequent therapy.老年起病型类风湿关节炎：鉴别诊断及一线治疗与后续治疗的选择
Drugs Aging. 2009;26(9):739-50. doi: 10.2165/11316740-000000000-00000.
8
Perception of improvement in patients with rheumatoid arthritis varies with disease activity levels at baseline.类风湿关节炎患者对病情改善的感知因基线疾病活动水平而异。
Arthritis Rheum. 2009 Mar 15;61(3):313-20. doi: 10.1002/art.24282.
9
Developments in the clinical understanding of rheumatoid arthritis.类风湿关节炎临床认识的进展
Arthritis Res Ther. 2009;11(1):204. doi: 10.1186/ar2535. Epub 2009 Jan 30.
10
Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study.类风湿关节炎中生物改善病情抗风湿药的逐步联合治疗与转换治疗比较：一项回顾性观察性研究的结果
Ann Rheum Dis. 2007 Aug;66(8):1059-65. doi: 10.1136/ard.2006.061820. Epub 2007 Feb 16.